Market icon

Which vaccines will RFK end recommendations for?

$1,351,493 Vol.

OUTCOME
% CHANCE

Rules

This market will resolve to "Yes" if the CDC has completely ended its recommendation for the listed vaccine, meaning it no longer recommends it for any category of individuals by December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to “No”.

A reduction in the scope of recommended recipients, or the removal of a recommendation for a specific type of vaccine for the listed disease (e.g. CDC removal of the recommendation for the live oral polio vaccine in 2022) without fully eliminating the recommendation will not be sufficient for a "Yes" resolution.

The resolution source will be official CDC announcements and guidance published on the CDC website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).
Volume
$1,351,493
End Date
Dec 31, 2025
Created At
Feb 22, 2025, 12:10 AM UTC
shield

Beware of external links.

$1,351,493 Vol.

Market icon

Which vaccines will RFK end recommendations for?

OUTCOME
% CHANCE

Influenza

$22,930 Vol.

2%

Hepatitis B

$161,413 Vol.

1%

COVID-19

$583,722 Vol.

1%

HPV

$311,973 Vol.

1%

Polio

$12,621 Vol.

<1%

Measles Mumps and Rubella

$258,835 Vol.

<1%

About

Volume
$1,351,493
End Date
Dec 31, 2025
Created At
Feb 22, 2025, 12:10 AM UTC
shield

Beware of external links.